MedPath

Genetics in the Effect of Caffeine on Fat Oxidation

Not Applicable
Completed
Conditions
Fat Burn
Caffeine
Genetic Predisposition
Interventions
Dietary Supplement: Acute caffeine supplementation
Registration Number
NCT05975489
Lead Sponsor
Universidad Francisco de Vitoria
Brief Summary

Genetic polymorphism on the effect of oral caffeine intake on fat oxidation during exercise has been studied in active and healthy population performing an incremental test on a cycle ergometer with 3-min stages at workloads from 30 to 70% of maximal oxygen uptake (VO2max). Participants performed this test after the ingestion of a) placebo; b) 3 mg/kg of caffeine; c) 6 mg/kg of caffeine. Fat oxidation rate during exercise was measured by indirect calorimetry. The influence of the CYP1A2 c.-163A\>C, GSTP c.313A\>G and PGC1a polymorphisms was evaluated to determine the effects on fat oxidation during exercise

Detailed Description

Caffeine is a natural stimulant with well-recognized sports performance benefits. Aside its performance-enhancing effect, caffeine has the potential of increasing fat utilization during aerobic exercise at submaximal intensities, lowering-down the contribution of carbohydrate as a fuel. This property of caffeine may provoke a glycogen-sparing effect in the skeletal muscle and liver for exercise situations where carbohydrate availability may be a challenge. Additionally, the capacity of caffeine to enhance fat utilization during exercise could be of interest for improving health outcomes as it may increase the rate of change in body composition in exercise programs. Genetic factors like CYP1A2 c.-163A\>C, GSTP c.313A\>G and PGC1a c.1444G\>A and C\>T polymorphisms could be associated with the capacity for fat oxidation during exercise. To date, it is unknown if genetics increases fat oxidation and MFO in the same proportion during morning and evening exercise trials in women. For this reason, the aim of the present study was to evaluate the influence of the tCYP1A2, GSTP and PGC1a polymorphisms on the effect of caffeine on fat oxidation and MFO in active and healthy population. The authors hypothesised that genetics would increase fat oxidation and MFO during exercise and this effect would be of similar magnitude at several caffeine doses.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria

To be non-smokers. To have low caffeine intake (i.e., < 50 mg of caffeine per day in the previous 2 months) To show no previous history of cardiopulmonary diseases or having suffered musculoskeletal injuries in the previous 6 months.

Exclusion Criteria

To have VO2max values below 40 ml/kg/min To be sedentary

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo intakeAcute caffeine supplementationA dose of 3 mg/kg of placebo (Cellulose, Guinama, Valencia, Spain) was ingested before the beginning of each test.
Caffeine 3mg/kg intakeAcute caffeine supplementationA dose of 3 mg/kg of caffeine (Bulk Powders, Essex, United Kingdom) was ingested before the beginning of each test.
Caffeine 6mg/kg intakeAcute caffeine supplementationA dose of 6 mg/kg of caffeine (Bulk Powders, Essex, United Kingdom) was ingested before the beginning of each test.
Primary Outcome Measures
NameTimeMethod
Genotype frequency of GSTP polymorphismBaseline

Samples shall be obtained by swabbing and scraping of the buccal mucosa by the participant. The c.1444G\>A (rs8192678) and C\>T (rs17650401) polymorphisms will be used.

Genotype frequency of PGC1a polymorphismsBaseline

Samples shall be obtained by swabbing and scraping of the buccal mucosa by the participant. The c.313A\>G (rs1695) polymorphism will be used.

Genotype frequency of CYP1A2 polymorphismBaseline

Samples shall be obtained by swabbing and scraping of the buccal mucosa by the participant. The c.-163A\>C (rs762551) polymorphism will be used.

Secondary Outcome Measures
NameTimeMethod
MFO2-months

Maximal fat oxidation during exercise

FATmax2-months

The intensity of exercise that elicits MFO

RPE2-months

Rate of percevied exertion during exercise

FAT and CHO oxidation2-months

Fat and carbohydrates oxidation

Trial Locations

Locations (1)

Universidad Francisco de Vitoria

🇪🇸

Pozuelo De Alarcón, Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath